Neurometrix, Inc.
Neurometrix, Inc., marketer of the Quell electrical nerve stimulation device, settled with the FTC in March 2020 over deceptive claims that the device treats pain throughout the body when worn below the knee. The FTC found the company falsely claimed clinical proof of efficacy and misrepresented FDA clearance as covering full-body pain treatment. As part of the settlement, Neurometrix agreed to pay $4 million and cease the challenged claims; nearly $3.9 million was subsequently returned to defrauded consumers in September 2020.
Flagged claims (3)
the device's efficacy is clinically proven
cleared by the FDA to treat pain throughout the body
the device treats pain throughout the body when placed below the knee
Required actions (4)
the marketers of an electrical nerve stimulation device called Quell have agreed to pay $4 million
stop making deceptive claims that the device treats pain throughout the body when placed below the knee
They also will stop claiming the device's efficacy is clinically proven and that it has been cleared by the FDA to treat pain throughout the body.
the FTC announced it was returning almost $3.9 million to defrauded consumers
Does your site contain similar claims?
The free site audit scans your site against every entry in this Atlas. Most functional medicine sites match 3-6 patterns.
Run my free site audit